Exact Mass: 324.111
Exact Mass Matches: 324.111
Found 213 metabolites which its exact mass value is equals to given mass value 324.111
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Furaltadone
D000890 - Anti-Infective Agents > D023303 - Oxazolidinones C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
Prazepam
Prazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine that is used in the treatment of anxiety disorders. It is a schedule IV drug in the U.S. Prazepam is believed to stimulate GABA receptors in the ascending reticular activating system. Since GABA is inhibitory, receptor stimulation increases inhibition and blocks both cortical and limbic arousal following stimulation of the brain stem reticular formation. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
Acetohexamide
Acetohexamide is only found in individuals that have used or taken this drug. It is a sulfonylurea hypoglycemic agent that is metabolized in the liver to 1-hydrohexamide. [PubChem]Sulfonylureas such as acetohexamide bind to an ATP-dependent K+ channel on the cell membrane of pancreatic beta cells. This inhibits a tonic, hyperpolarizing outflux of potassium, which causes the electric potential over the membrane to become more positive. This depolarization opens voltage-gated Ca2+ channels. The rise in intracellular calcium leads to increased fusion of insulin granulae with the cell membrane, and therefore increased secretion of (pro)insulin. A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents
N-(6-Cyano-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl)-N-methylethanesulfonamide
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
Mycocyclosin
An organic heterotetracyclic compound obtained via intramolecular oxidative aromatic coupling of cyclo(L-tyrosyl-L-tyrosyl). D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D054659 - Diketopiperazines
Chromanol 293B
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
(4-Acetamidophenyl) (2S)-2-acetamido-4-methylsulfanylbutanoate
Bicisate
3-((4-(5-(Hydroxymethyl)-2-oxo-3-oxazolidinyl)phenoxy)methyl)benzonitrile
Difructose anhydride III
N-(N-Formyl-L-methionyl)-L-phenylalanine
Furaltadone
2,2-Dimethyl-4-(4-methylsulfonylphenyl)-5-propoxyfuran-3-one
2,3,5,8,10-Pentahydroxy-3-methyl-6-methoxy-1,2,3,4,4a,9a-hexahydroanthracene-9(10H)-one
1,2-Dihydro,1-hydroxy-(8alpha,9beta)-form-1,7,8,9-Tetrahydro-1,9-dihydroxy-4-methoxy-5-methyl-8-(1-methylethenyl)-3H-furo[3,4-f][1]benzopyran-3-one,
(2E,8E)-2,8-Decadiene-4,6-diyne-1,10-diol 1-O-??-D-glucopyranoside|(2E,8E)-deca-2,8-diene-4,6-diyne-1,10-diol 1-O-beta-D-glucopyranoside
O-beta-D-Xylopyranoside-(R)-5,6,7,8-Tetrahydro-6-hydroxy-2-naphthalenecarboxylic acid
3(R)-deca-4,6,8-triyne-1,3-diol 1-O-beta-D-glucopyranoside|bidensyneoside B
2-(4-hydroxy-3-methoxyphenyl)-1,3-propanediol triacetate
5H-benzo[g]-1,3-benzodioxolo[5,6,4]quinoline-6,7,7a,8-tetrahydro-7-nitroso-10-methoxy-(7aR)|N-nitrosoxylopine
3-O-trans-p-methoxycinnamoyl-alpha-L-rhamnopyranose
5-Methoxy-6-methoxy-7-(2,3-dihydroxy-3-methylbutoxy)coumarin
3-(4-hydroxy-3-methoxyphenyl)-1,2-propanediol triacetate
6,9-dihydroxy-7,8-dimethoxy-2-propyl-2,3,3a,9b-tetrahydro-furo[3,2-c]isochromen-5-one|Hydroxymonocerin
prazepam
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents N - Nervous system > N05 - Psycholeptics > N05B - Anxiolytics > N05BA - Benzodiazepine derivatives C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
acetohexamide
A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4168; ORIGINAL_PRECURSOR_SCAN_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4170; ORIGINAL_PRECURSOR_SCAN_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4125; ORIGINAL_PRECURSOR_SCAN_NO 4121 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4143; ORIGINAL_PRECURSOR_SCAN_NO 4140 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4151; ORIGINAL_PRECURSOR_SCAN_NO 4150 ORIGINAL_PRECURSOR_SCAN_NO 4163; CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4165 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4165; ORIGINAL_PRECURSOR_SCAN_NO 4163 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8394; ORIGINAL_PRECURSOR_SCAN_NO 8389 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8413; ORIGINAL_PRECURSOR_SCAN_NO 8409 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8458; ORIGINAL_PRECURSOR_SCAN_NO 8454 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8489; ORIGINAL_PRECURSOR_SCAN_NO 8485 CONFIDENCE standard compound; INTERNAL_ID 894; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8471; ORIGINAL_PRECURSOR_SCAN_NO 8468
Bualta
6-(3-Hydroxyprop-1-ynyl)-1-(4-methoxybenzyl)-1H-pyrido[2,3-b][1,4]oxazin-2(3H)-one
Sumacetamol
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
Methyl 2-O-acetyl-4,6-O-benzylidene-a-D-glucopyranoside
methanesulfonic acid,2-(4-phenylmethoxyphenyl)ethanol
(3AR,4R,5R,6AS)-4-((E)-3,3-DIFLUORO-4-PHENOXYBUT-1-EN-1-YL)-5-HYDROXYHEXAHYDRO-2H-CYCLOPENTA[B]FURAN-2-ONE
ETHYL 1-BENZYL-4-HYDROXY-2-OXO-1,2-DIHYDRO-1,8-NAPHTHYRIDINE-3-CARBOXYLATE
Ethyl 4-hydroxy-7-methyl-2-oxo-1-phenyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate
N-{4-[(1-Acetyl-4-piperidinyl)carbonyl]phenyl}methanesulfonamide
4-HYDROXY-1-METHYL-2-OXO-1,2-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID (3-METHOXY-PHENYL)-AMIDE
1,3-Bis((3-methyl-2,5-dioxopyrrol-1-yl)methyl)benzol
5,5-dimethyl-2-[[(2-phenoxyacetyl)amino]methyl]-1,3-thiazolidine-4-carboxylic acid
Diethyl 2,2-(1,2-ethanediyldiimino)bis(3-sulfanylpropanoate)
2-Amino-5-[(1-Methoxy-2-Methylindolizin-3-Yl)carbonyl]benzoic Acid
N-(3-fluorophenyl)-2-oxo-4,10-dihydro-3H-pyrimido[1,2-a]benzimidazole-4-carboxamide
5-Chloro-6-methyl-N-(2-phenylethyl)-2-pyridin-2-ylpyrimidin-4-amine
(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide
(1r,4r,5s,6s,7r,10r,11s,12s)-1,7-Bis(Hydroxymethyl)-2,8,13,14-Tetraoxatricyclo[8.2.1.1~4,7~]tetradecane-5,6,11,12-Tetrol
3,6-anhydro-alpha-L-galactopyranosyl-(1->3)-D-galactose
alpha-D-fructofuranose beta-D-fructofuranose 1,2:1,2-dianhydride
N,N-((1Z,3Z)-1,4-bis(4-hydroxyphenyl)buta-1,3-diene-2,3-diyl)diformamide
A natural product found particularly in Aspergillus fumigatus and Penicillium notatum.
N4-(3-chlorophenyl)-6-methyl-N2-(phenylmethyl)pyrimidine-2,4-diamine
2-{2,5-dimethyl-3-[(E)-(4H-1,2,4-triazol-4-ylimino)methyl]-1H-pyrrol-1-yl}-4,5-dimethylthiophene-3-carbonitrile
N-[4-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
N-[3-[2-[(4-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
1-Phenylmethoxy-4-prop-2-enoxyquinoxaline-2,3-dione
1,3-Benzothiazol-2-yl-[4-(2-pyridinyl)-1-piperazinyl]methanone
N-[4-[2-[(6-methyl-2-pyridinyl)amino]-4-thiazolyl]phenyl]acetamide
N-[2-(4-methylphenoxy)-1-oxoethyl]-2-benzofurancarbohydrazide
2-[(4-methyl-2-oxo-1-benzopyran-7-yl)oxy]-N-(2-pyridinylmethyl)acetamide
6-Amino-4-(1-cyclohex-2-enyl)-3-thiophen-2-yl-2,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile
alpha-N-(9-beta-D-ribofuranosylpurin-6-yl)glycinamide
alpha-D-Fructofuranose beta-D-fructopyranose 1,2:2,1-dianhydride
3,4,5-trihydroxy-6-[(E)-2-methyl-3-phenylprop-2-enoxy]oxane-2-carboxylic acid
3,4,5-trihydroxy-6-[(E)-4-phenylbut-3-en-2-yl]oxyoxane-2-carboxylic acid
S-(2,5-Diacetoxy-3,4,6-trimethyl-phenylmethyl)thioacetate
Levofuraltadona
C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
bis-beta-D-fructofuranose 1,2:2,3-dianhydride
A sugar dianhydride obtained by the condensation of two units of beta-D-fructofuranose.
HMR1556
D002317 - Cardiovascular Agents > D026902 - Potassium Channel Blockers D049990 - Membrane Transport Modulators
1,4,6,7,10-pentahydroxy-3-methoxy-6-methyl-5,7,8,8a,10,10a-hexahydroanthracen-9-one
2-[(10-hydroxydeca-2,8-dien-4,6-diyn-1-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
(2r,4r,6r)-10-hydroxy-4-[(1r)-1-hydroxypropyl]-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
7-(2,3-dihydroxy-3-methylbutoxy)-6,8-dimethoxychromen-2-one
(2r,4s,6r)-10-hydroxy-4-(3-hydroxypropyl)-11,12-dimethoxy-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(9),10,12-trien-8-one
4,5,6-trihydroxy-2-methyloxan-3-yl 3-(4-methoxyphenyl)prop-2-enoate
n-[2-(2',6-dihydroxy-5'-{2-[(hydroxymethylidene)amino]ethenyl}-[1,1'-biphenyl]-3-yl)ethenyl]carboximidic acid
2,3,5-trihydroxy-6-methyloxan-4-yl 3-(4-methoxyphenyl)prop-2-enoate
(2r,4s,6r)-10,13-dihydroxy-11,12-dimethoxy-4-propyl-3,7-dioxatricyclo[7.4.0.0²,⁶]trideca-1(13),9,11-trien-8-one
(2 e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN005575","Ingredient_name": "(2 e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-\u03b2-d-glucopyranoside","Alias": "(2e,8 e)-2,8-decadiene-4,6-diyne-1,10-diol 1-o-\u03b2-d-glucopyranoside","Ingredient_formula": "C16H20O7","Ingredient_Smile": "C(C=CC#CC#CC=CCOC1C(C(C(C(O1)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT14913","TCMID_id": "4817","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
bidensyneoside b
{"Ingredient_id": "HBIN018480","Ingredient_name": "bidensyneoside b","Alias": "NA","Ingredient_formula": "C16H20O7","Ingredient_Smile": "CC#CC#CC#CC(CCOC1C(C(C(C(O1)CO)O)O)O)O","Ingredient_weight": "324.32 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2361","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10892676","DrugBank_id": "NA"}